22 Sep 2011 16:35
PuriCore plc Board and Organisational Changes
MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 22 September 2011 - PuriCore (LSE: PURI), the water-based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today announces the resignation of Darren Weiss as Chief Financial Officer and Executive Director to accept a new position. This change will be effective from 7 October 2011.
Christopher Wightman, Executive Chairman, said:
"We thank Darren for his many contributions to the Company over the past seven years and wish him success in his future endeavours. Whilst the Company has begun a search for his successor, the finance teams in both the UK and the US are led by strong individuals, and we are confident that our financial processes and teams in both locations will provide a seamless continuation of our financial operations and reporting."
Enquiries:
Financial Dynamics | PuriCore |
Susan Quigley | Chris Wightman |
Ben Brewerton | Executive Chairman |
+44 (0) 20 7831 3113 | +44 (0) 20 7290 3440 |
About PuriCore
PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. PuriCore's patented, proprietary technology mimics the human body's production of the natural antimicrobial hypochlorous acid, offering a safe and non-hazardous approach to disinfection and sanitisation. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. Hypochlorous acid is proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.
To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.